Related Experiment Video
Updated: Feb 15, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Multicenter US Clinical Trial With an Electric-Acoustic Stimulation (EAS) System in Adults: Final Outcomes
Harold C Pillsbury1, Margaret T Dillon1, Craig A Buchman1
1Department of Otolaryngology/Head and Neck Surgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
The MED-EL Electric-Acoustic Stimulation (EAS) System safely and effectively improved speech perception for adults with low-frequency residual hearing and severe-to-profound high-frequency hearing loss. Most participants showed significant gains, demonstrating the system
Area of Science:
- Otorhinolaryngology
- Audiology
- Biomedical Engineering
Background:
- Many adults experience residual low-frequency hearing with severe-to-profound high-frequency sensorineural hearing loss.
- Traditional hearing aids may not provide sufficient benefit for this patient population.
- Electric-Acoustic Stimulation (EAS) offers a combined approach of electric stimulation and acoustic amplification.
Purpose of the Study:
- To evaluate the safety and effectiveness of the MED-EL EAS System.
- To assess outcomes in adults with residual low-frequency hearing and severe-to-profound mid-to-high frequency hearing loss.
Main Methods:
- Prospective, multicenter study involving 73 adult subjects implanted with MED-EL PULSAR or SONATA cochlear implants and FLEX electrode arrays.
- Subjects were fitted with an audio processor combining electric stimulation and acoustic amplification postoperatively.
- Hearing thresholds and speech perception (using City University of New York sentences and consonant-nucleus-consonant words) were assessed at 3, 6, and 12 months postactivation.
Main Results:
- 92% of subjects completed all study intervals; 79% maintained low-frequency hearing thresholds within 30 dB HL.
- 97% could use the acoustic component at 12 months.
- In the EAS condition, 94% performed similarly or better on speech-in-noise tests, with 85% showing improvement; 97% improved on word recognition tests, with 84% demonstrating improvement.
Conclusions:
- The MED-EL EAS System is a safe and effective treatment for adults with specific patterns of hearing loss.
- This technology provides significant speech perception benefits for individuals not adequately served by conventional amplification.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

